Hypothesis of COVID-19 therapy with sildenafil
Backgound: Bacterial or viral infections often cause acute and severe systemic inflammation, which affects the lungs lipopolysaccharide (LPS), a pathogenic component of the membrane of gram-negative bacteria, stimulates active innate immune cells, monocytes, macrophages to produce inducible nitric o...
Main Authors: | Limodio Mario, Menicagli Roberto, Limodio Marta, Casotti Maria Teresa, Menicagli Laura |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | International Journal of Preventive Medicine |
Subjects: | |
Online Access: | http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2020;volume=11;issue=1;spage=76;epage=76;aulast=Mario |
Similar Items
-
Pulmonary Covid fibrosis a new pharmaceutic approach
by: Roberto Menicagli, et al.
Published: (2021-01-01) -
COVID-19 solution
by: Roberto Menicagli, et al.
Published: (2020-01-01) -
Sildenafil citrate therapy for secondary pulmonary arterial hypertension due to chronic obstructive lung disease
by: Khaled Alkhayat, et al.
Published: (2016-10-01) -
Enhanced dissolution of sildenafil dry foam tablets
by: Somchai Sawatdee, et al.
Published: (2016-02-01) -
Sildenafil citrate for the management of fetal growth restriction and oligohydramnios
by: Choudhary R, et al.
Published: (2016-08-01)